Company: XTKG
Filing Date: 2025-07-17
Form Type: 424B5
Source: 0001213900-25-064921
Chunk: 48

Company: X3 Holdings Co., Ltd.
Filing Date: 2025-07-17
Form: 424B5
Chunk 48
---
 any options to purchase
additional securities held by them will be described in the applicable prospectus supplement. For a more complete description of the
plan of distribution of these securities, see the section entitled “Plan of Distribution” on page 13.

If any underwriters are involved
in the sale of the securities with respect to which this prospectus is being delivered, the names of such underwriters and any applicable
discounts or commissions and over-allotment options will be set forth in the applicable prospectus supplement. This prospectus also describes
the general manner in which our securities may be offered and sold. If necessary, the specific manner in which our securities may be
offered and sold will be described in a supplement to this prospectus.

Pursuant to General Instruction
I.B.5. of Form F-3, in no event will we sell the securities covered hereby in a public primary offering with a value exceeding more than
one-third of the aggregate market value of our ordinary shares in any 12-month period so long as the aggregate market value of our outstanding
ordinary shares held by non-affiliates remains below $75,000,000 (the “Baby Shelf Limitation”). As of January 10, 2025, the
aggregate market value of our outstanding ordinary shares held by non-affiliates was approximately $18.85 million, based on 13,755,975
ordinary shares held by non-affiliates as of such date at a price of $1.37 per share on January 10, 2025, which was the highest closing
price of our ordinary shares on Nasdaq within 60 days of the filing date of this registration statement. During the 12 calendar months
prior to and including the date of this prospectus, we have not offered or sold any securities pursuant to General Instruction I.B.5
of Form F-3.

Our Ordinary Shares are currently
listed on Nasdaq under the symbol “XTKG.” On March 3, 2025, the last reported sale price of our ordinary shares on Nasdaq
was US$0.556 per share. The applicable prospectus supplement will contain information, where applicable, as to other listings, if any,
on Nasdaq or other securities exchange of the securities covered by the prospectus supplement.

Investing in our securities involves risks. You should carefully review the risks described under the heading “Risk Factors” beginning on page 10 and in the documents which are incorporated by reference herein before you invest in our